← Back to Search

Prescription Digital Therapeutic

Single arm for Schizophrenia

N/A
Waitlist Available
Research Sponsored by Click Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has outpatient treatment status of schizophrenia.
Is on a stable dose of antipsychotic medication(s)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from week 3 to week 7 of the mobile agnew relationships measure
Awards & highlights

Study Summary

CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from week 3 to week 7 of the mobile agnew relationships measure
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from week 3 to week 7 of the mobile agnew relationships measure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility and acceptability with the study app as measured by Mobile App Rating Scale (MARS) at week 7
Secondary outcome measures
Change in strength of digital working alliance from Week 3 to Week 7 as assessed by the Mobile Agnew Relationships Measure (mARM)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Single arm acceptability and feasibility of CT-155.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CT-155 smartphone app
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Click Therapeutics, Inc.Lead Sponsor
15 Previous Clinical Trials
2,917 Total Patients Enrolled
4 Trials studying Schizophrenia
749 Patients Enrolled for Schizophrenia
Shaheen Lakhan, MDPhD, FAANStudy ChairClick Therapeutics
4 Previous Clinical Trials
286 Total Patients Enrolled
1 Trials studying Schizophrenia
48 Patients Enrolled for Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~19 spots leftby Mar 2025